The agreement with Pfizer is part of the Trump administration's strategy to implement the 'most favored nation' model, ensuring that the U.S. pays competitive prices for medications. Pfizer will reduce prices on a large scale and will launch the 'TrumpRx' platform for direct sales to patients. Additionally, the company will invest 70 billion dollars in research and production in the U.S.
Sources
Latest News
12:06
A drone illegally flew over the airspace of the Republic of Moldova, in the Palanca area, the Ministry of Defense announced
11:59
AirBaltic goes bankrupt due to rising fuel prices amid the war in Iran
11:53
Bucharest Bar lawyer indicted for tax evasion. Undeclared income of over 652,000 lei
11:42
60,000 toys suspected of infringing intellectual property rights seized at the Port of Constanța
11:37
The Commission is checking the safety of OpenAI agents after incidents in which they exceeded internet access limits
See more news